Improving access to HIV prevention through counselor-led programs
Scaling up for impact: HIV testing counselor-led pathway to accelerate PrEP delivery at scale
This study is looking at how trained counselors in family planning clinics can make it easier for people to get HIV prevention medication called PrEP, so more individuals can access it without the hassle of long waits or complicated processes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11006585 on NIH RePORTER |
What this research studies
This research focuses on enhancing the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention by utilizing trained HIV testing counselors in family planning clinics. The approach aims to simplify the process for potential PrEP clients, addressing barriers such as long wait times and complex health system navigation. By implementing a model that allows counselors to screen for PrEP eligibility, the study seeks to increase the number of individuals who can access and initiate PrEP, ultimately improving public health outcomes in the community.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for HIV who are seeking preventive options and are able to access family planning clinics in the study areas.
Not a fit: Patients who are not at risk for HIV or those who do not have access to the participating clinics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of individuals accessing effective HIV prevention methods, thereby reducing the incidence of HIV in the community.
How similar studies have performed: Previous research has shown success in similar models of PrEP delivery, indicating that this approach has the potential to be effective.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Mugwanya, Kenneth Kiggundu — University of Washington
- Study coordinator: Mugwanya, Kenneth Kiggundu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.